The Association of British HealthTech Industries (ABHI) has submitted a comprehensive response to the UK government's Industrial Strategy Green Paper, focusing on the HealthTech sector. ABHI has proposed significant reforms to regulatory processes, including recognition of approvals from trusted jurisdictions, and improvements to NHS procurement and adoption pathways. The association has also highlighted barriers to investment and growth, suggesting measures to enhance data sharing, infrastructure, and alignment with devolved governments' strategies. ABHI emphasizes the need for a tailored approach to HealthTech within the broader Life Sciences sector, advocating for dedicated representation and policy considerations to unlock the sector's full potential for economic growth and healthcare innovation.

The Association of British HealthTech Industries (ABHI) has published its manifesto, The Plan for Health Tech, which sets out a ten-point programme for the government to ensure that the health sector’s potential is fully realised to benefit patients, clinicians and the economy. The manifesto recommends a focus on regulatory alignment, fostering innovation in healthcare practices and ensuring a long-term investment to support sector growth. The manifesto also calls for increased collaboration with NHS England and other healthcare providers to streamline technology adoption and expanded digital infrastructure to enhance early diagnosis and patient care.

The Association of British HealthTech Industries (ABHI) has published its response to the European Commission’s call for evidence on the targeted revision of the Medical Device Regulation (MDR) (EU) 2017/745 and In Vitro Diagnostic Medical Device Regulation (IVDR) (EU) 2017/746. ABHI supports the Commission’s objectives to improve device availability and simplify regulatory processes. It advocates for: (1) risk-based, proportionate regulation; (2) streamlined requirements for low-risk and legacy devices; and (3) platform-based certification for combination products. The response also calls for harmonised approaches to clinical evidence generation, ethics review and data collection, recognising the role of medical devices, IVDs, software, and AI within broader clinical research frameworks.

The Association of British HealthTech Industries (ABHI) has published guidance on 17 April 2025 explaining the United States Food and Drug Administration (FDA) 510(k) medical device approval process. The document aims to inform UK policymakers considering regulatory alignment with the US system post-Brexit. It addresses 12 common misconceptions about the 510(k) pathway and outlines how elements such as risk-based classification and recognition of prior assessments could be incorporated into UK reforms. The guidance specifically examines the process's application to both medical devices and in vitro diagnostics.

The Association of British HealthTech Industries (ABHI) has released a report on the economic impact of the HealthTech policies drawn up by ABHI in collaboration with Lord Sainsbury’s Gatsby Foundation and Imperial College London at the beginning of 2024. While the report found that HealthTech has had a significant impact on the economy, adding £13bn to the biopharmaceutical sector, it also noted that HealthTech’s growth potential should be increased through policy measures on tax incentives, regulatory reforms, and collaboration with the NHS. The report also outlines short, medium, and long-term recommendations to increase NHS efficiency, investment in research and development, and enhance ABHI’s Global Export Programme.

The Association of British HealthTech Industries (ABHI) has released a survey revealing significant financial pressures on the UK's HealthTech sector. The organisation reports that 70% of respondents have experienced substantial cost increases, with half anticipating annual rises above £100,000 due to the National Insurance Contributions (NIC) increase.

The Association of British Insurers is a trade association representing the vast majority of UK insurers (both general and life). It has a decreasing influence in pensions policy but is active on institutional investment matters such as shareholder action and remuneration policies of quoted companies. It does not always agree with the Pensions and Lifetime Savings Association (formerly the NAPF) which looks after the interests of company pension funds.

Form of performance guarantee bond produced by the Association of British Insurers (ABI) and commonly used in relation to construction projects, although it is often amended.

The Association of British Insurers (ABI) and Lloyd’s of London have co-published: the Components of a Major Cyber Event: A (Re)Insurance Approach, as a guide for (re)insurers on how to approach defining a major cyber event. The guide sets out factors re(insurers) should consider and provides a framework to follow when defining what constitutes a major cyber event.

Law360: The Association of British Insurers (ABI) has said it has signed a memorandum of understanding with a trade group for insurance technology companies to support and promote innovation on artificial intelligence, open finance, data ethics and operational resilience.

The Association of British Insurers (ABI) has announced its new Chair of the ABI’s Protection Board, Fran Bruce, managing director for protection at Aviva UK, replacing Aviva’s Paul Brencher. The ABI’s Protection Board sets the strategic direction of the ABI’s work on protection policy and proactively identifies areas to drive better standards across the industry that improve customer experience, access and understanding of insurance.

The Association of British Insurers (ABI) has established a Pension Insurance and Investment Board to strengthen its policy focus on pension insurance, annuities and investment. The Board will oversee policy relating to defined benefit pensions, annuity investment and the bulk purchase annuity market. It will also assume oversight of the Investment Delivery Forum, set up to drive and monitor the £100bn investment commitment made during Solvency II framework reform discussions. The new Board will be chaired by the Chief Executive Officer of Just Group, David Richardson, who will also join the ABI Board. The changes form part of broader governance changes that give product boards greater responsibility for setting policy within their respective markets.